Abstract | PURPOSE: The aim of the study was to evaluate the feasibility of using the hepatocyte-specific positron emission tomography (PET) tracer 2-[(18)F]fluoro-2-deoxy- D-galactose ( FDGal) as a tracer for hepatocellular carcinoma (HCC). METHODS: In addition to standard clinical investigations, 39 patients with known HCC or suspected of having HCC underwent a partial-body FDGal PET/CT (from base of skull to mid-thigh). Diagnosis of HCC was based on internationally approved criteria. FDGal PET/CT images were analysed for areas with high (hot spots) or low (cold spots) tracer accumulation when compared to surrounding tissue. RESULTS: Seven patients did not have HCC and FDGal PET/CT was negative in each of them. Twenty-three patients had HCC and were included before treatment. FDGal PET/CT correctly identified 22 of these patients, which was comparable to contrast-enhanced CT. Interestingly, FDGal PET/CT was conclusive in 12 patients in whom conventional imaging techniques were inconclusive and required additional diagnostic investigations or close follow-up. Nine patients were included after treatment of HCC and in these patients FDGal PET/CT was able to distinguish between viable tumour tissue as hot spots and areas with low metabolic activity as cold spots. FDGal PET/CT detected extrahepatic disease in nine patients which was a novel finding in eight patients. CONCLUSION:
FDGal PET/CT has great clinical potential as a PET tracer for detection of extra- but also intrahepatic HCC. In the present study, the specificity of FDGal PET/CT was 100%, which is very promising but needs to be confirmed in a larger, prospective study.
|
Authors | Michael Sørensen, Kim Frisch, Dirk Bender, Susanne Keiding |
Journal | European journal of nuclear medicine and molecular imaging
(Eur J Nucl Med Mol Imaging)
Vol. 38
Issue 9
Pg. 1723-31
(Sep 2011)
ISSN: 1619-7089 [Electronic] Germany |
PMID | 21553087
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Radioactive Tracers
- Fucose
- 2-deoxy-2-fluorogalactose
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Biological Transport
- Carcinoma, Hepatocellular
(diagnostic imaging, metabolism)
- Feasibility Studies
- Female
- Fucose
(analogs & derivatives)
- Humans
- Liver Neoplasms
(diagnostic imaging, metabolism)
- Male
- Middle Aged
- Multimodal Imaging
(methods)
- Positron-Emission Tomography
- Radioactive Tracers
- Retrospective Studies
- Tomography, X-Ray Computed
|